A therapeutic trial of pro-methylation dietary supplements in Angelman syndrome

American Journal of Medical Genetics, Part A

Volumn 155, Issue 12, 2011, Pages 2956-2963

  Bird, Lynne M ^a,b,c   Tan, Wen Hann ^a,d,e   Bacino, Carlos A ^a,f,g   Peters, Sarika U ^a,h,i   Skinner, Steven A ^a,j   Anselm, Irina ^a,d,e   Barbieri Welge, Rene ^a,c   Bauer Carlin, Astrid ^a,j   Gentile, Jennifer K ^a,d,e   Glaze, Daniel G ^a,f,g   Horowitz, Lucia T ^a,j   Mohan, K Naga ^g   Nespeca, Mark P ^a,c,k   Sahoo, Trilochan ^a,g,l   Sarco, Dean ^a,d,e,m   Waisbren, Susan E ^a,d,e   Beaudet, Arthur L ^a,f,g  

^a Prader Willi Syndromes Consortium   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f TEXAS CHILDREN S HOSPITAL   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h VANDERBILT UNIVERSITY   (United States)

ⁱ VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^j GREENWOOD GENETIC CENTER   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^m Kaiser Permanente ^*  (United States)

more..

Author keywords

Angelman syndrome; Clinical trial; Dietary supplements; Methylation

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; BETAINE; CREATINE; CYANOCOBALAMIN; HOMOCYSTEINE; METAFOLIN; METHIONINE SYNTHASE; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG;

ABNORMAL LABORATORY RESULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANOREXIA; ARTICLE; BEHAVIOR DISORDER; CHILD; CHILD DEVELOPMENT; COGNITIVE DEVELOPMENT; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DIARRHEA; DIET SUPPLEMENTATION; DISEASE SEVERITY; DNA METHYLATION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GENE; GENE EXPRESSION REGULATION; HAPPY PUPPET SYNDROME; HUMAN; INCREASED APPETITE; INFANT; INFECTION; LANGUAGE ABILITY; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; ODOR; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEIZURE; SERUM SICKNESS; SIDE EFFECT; SLEEP DISORDER; TREATMENT DURATION; UBIQUITIN PROTEIN LIGASE 3A GENE; UPREGULATION;

ANGELMAN SYNDROME; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; DNA METHYLATION; FEMALE; HUMANS; INFANT; MALE; PSYCHOMETRICS; TREATMENT OUTCOME;

EID: 81955161925     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.34297     Document Type: Article

References (27)

1. Bayley N. Bayley scales of infant and toddler development, third edition (Bayley-III). San Antonio, TX: Harcourt Assessment, Inc. 2005.
2. Chamberlain SJ, Lalande M. 2010. Angelman syndrome, a genomic imprinting disorder of the brain. J Neurosci 30: 9958-9963.
3. Clayton-Smith J, Laan L. 2003. Angelman syndrome: A review of the clinical and genetic aspects. J Med Genet 40: 87-95.
4. Dindot SV, Antalffy BA, Bhattacharjee MB, Beaudet AL. 2008. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum Mol Genet 17: 111-118.
5. Dykens EM, Hodapp RM, Evans DW. 1994. Profiles and development of adaptive behavior in children with Down syndrome. Am J Ment Retard 98: 580-587.
6. Freeman SB, May KM, Pettay D, Fernhoff PM, Hassold TJ. 1993. Paternal uniparental disomy in a child with a balanced 15;15 translocation and Angelman syndrome. Am J Med Genet 45: 625-630.
7. Gustin RM, Bichell TJ, Bubser M, Daily J, Filonova I, Mrelashvili D, Deutch AY, Colbran RJ, Weeber EJ, Haas KF. 2010. Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome. Neurobiol Dis 39: 283-291.
8. Jiang Y, Lev-Lehman E, Bressler J, Tsai TF, Beaudet AL. 1999. Genetics of Angelman syndrome. Am J Hum Genet 65: 1-6.
9. Jiang Y, Tsai TF, Bressler J, Beaudet AL. 1998a. Imprinting in Angelman and Prader-Willi syndromes. Curr Opin Genet Dev 8: 334-342.
10. Jiang YH, Armstrong D, Albrecht U, Atkins CM, Noebels JL, Eichele G, Sweatt JD, Beaudet AL. 1998b. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21: 799-811.
11. Kashiwagi A, Meguro M, Hoshiya H, Haruta M, Ishino F, Shibahara T, Oshimura M. 2003. Predominant maternal expression of the mouse Atp10c in hippocampus and olfactory bulb. J Hum Genet 48: 194-198.
12. Lord C, Rutter M, DiLavore PC, Risi S. 2002. Autism diagnostic observation schedule. Los Angeles: Western Psychological Services.
13. Lord C, Rutter M, LeCouteur A. 1998. Autism diagnostic interview-Revised. Los Angeles: Western Psychological Services.
14. Lossie AC, Whitney MM, Amidon D, Dong HJ, Chen P, Theriaque D, Hutson A, Nicholls RD, Zori RT, Williams CA, Driscoll DJ. 2001. Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet 38: 834-845.
15. Peters SU, Bird LM, Kimonis V, Glaze DG, Shinawi LM, Bichell TJ, Barbieri-Welge R, Nespeca M, Anselm I, Waisbren S, Sanborn E, Sun Q, O'Brien WE, Beaudet AL, Bacino CA. 2010. Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid. Am J Med Genet A 152A: 1994-2001.
16. Peters SU, Horowitz L, Barbieri-Welge R, Taylor JL, Hundley R. 2011. Longitudinal follow-up of autism spectrum features and sensory behaviors in Angelman Syndrome by deletion class. J Child Psychol Psychiatry, DOI: 10.1111/j.1469-7610.2011.02455.x. in press.
17. Rougeulle C, Glatt H, Lalande M. 1997. The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain. Nat Genet 17: 14-15.
18. Sacks H, Chalmers TC, Smith H Jr. 1982. Randomized versus historical controls for clinical trials. Am J Med 72: 233-240.
19. Saitoh S, Buiting K, Cassidy SB, Conroy JM, Driscoll DJ, Gabriel JM, Gillessen-Kaesbach G, Glenn CC, Greenswag LR, Horsthemke B, Kondo I, Kuwajimi K, Niikawa N, Rogan PK, Schwartz S, Seip J, Williams CA, Nicholls RD. 1997. Clinical spectrum and molecular diagnosis of Angelman and Prader-Willi syndrome patients with an imprinting mutation. Am J Med Genet 68: 195-206.
20. Sparrow SS, Cicchetti DV, Balla DA. 2005. Vineland adaptive behavior scales, second edition (Vineland-II). Upper Saddle River, NJ: Pearson Education, Inc.
21. Vu TH, Hoffman AR. 1997. Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain. Nat Genet 17: 12-13.
22. Williams CA, Angelman H, Clayton-Smith J, Driscoll DJ, Hendrickson JE, Knoll JH, Magenis RE, Schinzel A, Wagstaff J, Whidden EM, Zori RT. 1995a. Angelman syndrome: Consensus for diagnostic criteria. Angelman Syndrome Foundation. Am J Med Genet 56: 237-238.
23. Williams CA, Beaudet AL, Clayton-Smith J, Knoll JH, Kyllerman M, Laan LA, Magenis RE, Moncla A, Schinzel AA, Summers JA, Wagstaff J. 2006. Angelman syndrome 2005: Updated consensus for diagnostic criteria. Am J Med Genet A 140A: 413-418.
24. Williams CA, Frias JL. 1982. The Angelman ("happy puppet") syndrome. Am J Med Genet 11: 453-460.
25. Williams CA, Zori RT, Hendrickson J, Stalker H, Marum T, Whidden E, Driscoll DJ. 1995b. Angelman syndrome. Curr Probl Pediatr 25: 216-231.
26. Zimmerman IL, Steiner VG, Pond RE. 2002. Preschool language scale, 4th edition. San Antonio, TX: NC Pearson.
27. Zori RT, Hendrickson J, Woolven S, Whidden EM, Gray B, Williams CA. 1992. Angelman syndrome: Clinical profile. J Child Neurol 7: 270-280.